GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $384,000 | -4.2% | 8,827 | -4.1% | 0.05% | +15.0% |
| Q1 2022 | $401,000 | -2.7% | 9,201 | -1.6% | 0.04% | +2.6% |
| Q4 2021 | $412,000 | +11.7% | 9,351 | -3.1% | 0.04% | +2.6% |
| Q3 2021 | $369,000 | -0.8% | 9,651 | +3.2% | 0.04% | 0.0% |
| Q2 2021 | $372,000 | +11.4% | 9,351 | 0.0% | 0.04% | +5.6% |
| Q1 2021 | $334,000 | -4.3% | 9,351 | -1.3% | 0.04% | -10.0% |
| Q4 2020 | $349,000 | -3.1% | 9,473 | -1.0% | 0.04% | -13.0% |
| Q3 2020 | $360,000 | -8.4% | 9,573 | -0.5% | 0.05% | -11.5% |
| Q2 2020 | $393,000 | +7.7% | 9,623 | 0.0% | 0.05% | -7.1% |
| Q1 2020 | $365,000 | -19.2% | 9,623 | 0.0% | 0.06% | +1.8% |
| Q4 2019 | $452,000 | +13.6% | 9,623 | +3.2% | 0.06% | +3.8% |
| Q3 2019 | $398,000 | +6.7% | 9,323 | 0.0% | 0.05% | +6.0% |
| Q2 2019 | $373,000 | -5.8% | 9,323 | -1.5% | 0.05% | -3.8% |
| Q1 2019 | $396,000 | +8.2% | 9,467 | -1.2% | 0.05% | +8.3% |
| Q4 2018 | $366,000 | -4.9% | 9,580 | 0.0% | 0.05% | +9.1% |
| Q3 2018 | $385,000 | -7.5% | 9,580 | -7.0% | 0.04% | -12.0% |
| Q2 2018 | $416,000 | +3.2% | 10,300 | -0.0% | 0.05% | +2.0% |
| Q1 2018 | $403,000 | +10.4% | 10,303 | 0.0% | 0.05% | +11.4% |
| Q4 2017 | $365,000 | -13.1% | 10,303 | -0.6% | 0.04% | -21.4% |
| Q3 2017 | $420,000 | -6.0% | 10,362 | 0.0% | 0.06% | -12.5% |
| Q2 2017 | $447,000 | +8.8% | 10,362 | +6.3% | 0.06% | +3.2% |
| Q1 2017 | $411,000 | +834.1% | 9,752 | +768.4% | 0.06% | +675.0% |
| Q4 2016 | $44,000 | -29.0% | 1,123 | -21.9% | 0.01% | -27.3% |
| Q3 2016 | $62,000 | +37.8% | 1,437 | +38.6% | 0.01% | +37.5% |
| Q2 2016 | $45,000 | +55.2% | 1,037 | +43.4% | 0.01% | +60.0% |
| Q1 2016 | $29,000 | -38.3% | 723 | -37.9% | 0.01% | -37.5% |
| Q4 2015 | $47,000 | +6.8% | 1,164 | 0.0% | 0.01% | 0.0% |
| Q3 2015 | $44,000 | -20.0% | 1,164 | -12.5% | 0.01% | -20.0% |
| Q2 2015 | $55,000 | -9.8% | 1,330 | 0.0% | 0.01% | -9.1% |
| Q1 2015 | $61,000 | +24.5% | 1,330 | +14.3% | 0.01% | +22.2% |
| Q4 2014 | $49,000 | -9.3% | 1,164 | 0.0% | 0.01% | -10.0% |
| Q3 2014 | $54,000 | -12.9% | 1,164 | 0.0% | 0.01% | 0.0% |
| Q2 2014 | $62,000 | +63.2% | 1,164 | +61.0% | 0.01% | +66.7% |
| Q1 2014 | $38,000 | 0.0% | 723 | 0.0% | 0.01% | 0.0% |
| Q4 2013 | $38,000 | -22.4% | 723 | -25.8% | 0.01% | -33.3% |
| Q3 2013 | $49,000 | 0.0% | 975 | 0.0% | 0.01% | 0.0% |
| Q2 2013 | $49,000 | – | 975 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 6,324,319 | $241,621,000 | 32.36% |
| Black Creek Investment Management Inc. | 10,329,349 | $394,684,000 | 11.46% |
| Healthcare Value Capital, LLC | 100,000 | $3,821,000 | 7.54% |
| KAHN BROTHERS GROUP INC | 1,353,358 | $51,711,809,000 | 7.28% |
| EQUITY INVESTMENT CORP | 2,924,326 | $111,738,000 | 4.28% |
| Eversept Partners, LP | 1,503,700 | $57,456,377 | 3.99% |
| NKCFO LLC | 269,500 | $10,298,000 | 3.45% |
| Robinson Value Management, Ltd. | 96,990 | $3,706,000 | 3.31% |
| Keystone Financial Planning, Inc. | 237,691 | $9,082,000 | 3.30% |
| CLIFFORD CAPITAL PARTNERS LLC | 93,485 | $3,572,000 | 3.27% |